mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-10 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-10 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
9e-10 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-10 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-09 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-09 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-08 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |